| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Kidney Failure, Chronic | D007676 | 51 associated lipids |
| Hypercalcemia | D006934 | 13 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Dermatitis, Contact | D003877 | 59 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Mycobacterium Infections | D009164 | 7 associated lipids |
| Kidney Neoplasms | D007680 | 29 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
Glucaric acid
Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Glucaric acid?
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Glucaric acid
PubChem Associated disorders and diseases
What pathways are associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Glucaric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Glucaric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Glucaric acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with Glucaric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Glucaric acid?
Knock-out
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Glucaric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Nomoto H et al. | A case of osteomalacia due to deranged mineral balance caused by saccharated ferric oxide and short-bowel syndrome: A case report. | 2017 | Medicine (Baltimore) | pmid:28953654 |
| Deng Y et al. | Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study. | 2017 | Med. Sci. Monit. | pmid:28285317 |
| Derman R et al. | A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia. | 2017 | Am. J. Hematol. | pmid:28052413 |
| Lee T et al. | Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. | 2017 | Gut | pmid:26848182 |
| Faber F et al. | Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion. | 2016 | Nature | pmid:27309805 |
| Tiwari P et al. | Preventive effects of butyric acid, nicotinamide, calcium glucarate alone or in combination during the 7, 12-dimethylbenz (a) anthracene induced mouse skin tumorigenesis via modulation of K-Ras-PI3K-AKTpathway and associated micro RNAs. | 2016 | Biochimie | pmid:26655363 |
| Fell LH et al. | Impact of individual intravenous iron preparations on the differentiation of monocytes towards macrophages and dendritic cells. | 2016 | Nephrol. Dial. Transplant. | pmid:27190361 |
| Song D et al. | AMD-like retinopathy associated with intravenous iron. | 2016 | Exp. Eye Res. | pmid:27565570 |
| Gemici C et al. | Is there any role of intravenous iron for the treatment of anemia in cancer? | 2016 | BMC Cancer | pmid:27542823 |
| Zager RA et al. | Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure. | 2016 | Kidney Int. | pmid:27165818 |
| Montano-Pedroso JC et al. | Postoperative intravenously administered iron sucrose versus postoperative orally administered iron to treat post-bariatric abdominoplasty anaemia (ISAPA): the study protocol for a randomised controlled trial. | 2016 | Trials | pmid:27068478 |
| Han YM et al. | Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea. | 2016 | Gut Liver | pmid:27021505 |
| Barbieri C et al. | Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients. | 2016 | PLoS ONE | pmid:26939055 |
| Bitsi S et al. | Profound hyperglycemia in knockout mutant mice identifies novel function for POU4F2/Brn-3b in regulating metabolic processes. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:26670484 |
| Airy M et al. | Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients. | 2015 | Nephrol. Dial. Transplant. | pmid:26311216 |
| Minami D et al. | Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model. | 2015 | Cancer Sci. | pmid:26211743 |
| Ren X et al. | Effect of Intravenous Iron Supplementation on Acute Mountain Sickness: A Preliminary Randomized Controlled Study. | 2015 | Med. Sci. Monit. | pmid:26175087 |
| Agarwal R et al. | A randomized trial of intravenous and oral iron in chronic kidney disease. | 2015 | Kidney Int. | pmid:26083656 |
| Connor JR et al. | Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations. | 2015 | PLoS ONE | pmid:25973894 |
| Bhandari S et al. | A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients. | 2015 | Nephrol. Dial. Transplant. | pmid:25925701 |
| Toblli JE et al. | Cardiovascular outcomes of intravenous iron in perspective of clinical trials and the use of different iron preparations. | 2015 | Int. J. Cardiol. | pmid:25838213 |
| Dai P et al. | Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids. | 2015 | AAPS J | pmid:25762448 |
| Toblli JE et al. | Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron. | 2015 | Heart Lung Circ | pmid:25666998 |
| Shiue E et al. | Improving product yields on D-glucose in Escherichia coli via knockout of pgi and zwf and feeding of supplemental carbon sources. | 2015 | Biotechnol. Bioeng. | pmid:25258165 |
| Tiwari P et al. | Combinatorial chemopreventive effect of butyric acid, nicotinamide and calcium glucarate against the 7,12-dimethylbenz(a)anthracene induced mouse skin tumorigenesis attained by enhancing the induction of intrinsic apoptotic events. | 2015 | Chem. Biol. Interact. | pmid:25478867 |
| Barot BS et al. | Physicochemical and structural characterization of iron-sucrose formulations: a comparative study. | 2014 | Pharm Dev Technol | pmid:23701359 |
| Wang Y et al. | Hepatoprotective effects of kombucha tea: identification of functional strains and quantification of functional components. | 2014 | J. Sci. Food Agric. | pmid:23716136 |
| Almilaji A et al. | Regulation of the voltage gated K channel Kv1.3 by recombinant human klotho protein. | 2014 | Kidney Blood Press. Res. | pmid:25571875 |
| Sasaki Y et al. | Hepcidin production in response to iron is controlled by monocyte-derived humoral factors. | 2014 | Int. J. Hematol. | pmid:24293278 |
| Raman S et al. | Evolution-guided optimization of biosynthetic pathways. | 2014 | Proc. Natl. Acad. Sci. U.S.A. | pmid:25453111 |
| Lu QY et al. | Overestimation of flavonoid aglycones as a result of the ex vivo deconjugation of glucuronides by the tissue β-glucuronidase. | 2014 | J Pharm Biomed Anal | pmid:24176739 |
| Beguin Y and Jaspers A | Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas. | 2014 | Expert Opin Pharmacother | pmid:25186219 |
| Price E et al. | A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL. | 2014 | Blood Cells Mol. Dis. | pmid:25065855 |
| Kuo KL et al. | Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD. | 2014 | J. Am. Soc. Nephrol. | pmid:24722448 |
| Macdougall IC et al. | A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD. | 2014 | Clin J Am Soc Nephrol | pmid:24458078 |
| Contreras C et al. | Comparative study of the oral absorption of microencapsulated ferric saccharate and ferrous sulfate in humans. | 2014 | Eur J Nutr | pmid:23892521 |
| Corwin HL and Napolitano LM | Anemia in the critically ill: do we need to live with it?*. | 2014 | Crit. Care Med. | pmid:25126804 |
| Pieracci FM et al. | A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*. | 2014 | Crit. Care Med. | pmid:24797376 |
| Hetzel D et al. | A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. | 2014 | Am. J. Hematol. | pmid:24639149 |
| Perelló MF et al. | Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial. | 2014 | BJOG | pmid:24423186 |
| Toyokuni S | Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis. | 2014 | Redox Rep. | pmid:24257681 |
| Onken JE et al. | Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. | 2014 | Nephrol. Dial. Transplant. | pmid:23963731 |
| Shah RB et al. | Pharmaceutical characterization and thermodynamic stability assessment of a colloidal iron drug product: iron sucrose. | 2014 | Int J Pharm | pmid:24440404 |
| Tiwari P and Gupta KP | Modulation of miR-203 and its regulators as a function of time during the development of 7, 12 dimethylbenz [a] anthracene induced mouse skin tumors in presence or absence of the antitumor agents. | 2014 | Toxicol. Appl. Pharmacol. | pmid:24792773 |
| Elford P et al. | Biodistribution and predictive hepatic gene expression of intravenous iron sucrose. | 2013 Nov-Dec | J Pharmacol Toxicol Methods | pmid:23624021 |
| Soufras GD et al. | Fatal anaphylactic reaction to iron sucrose in pregnancy: iron-induced Kounis syndrome? | 2013 Nov-Dec | Indian J Pharmacol | pmid:24347784 |
| Mishra A et al. | Fatal anaphylactic reaction to iron sucrose in pregnancy. | 2013 Jan-Feb | Indian J Pharmacol | pmid:23543624 |
| Palmer K et al. | Review of available intravenous iron preparations in hemodialysis. | 2013 Apr-Jun | CANNT J | pmid:24069699 |
| Reinisch W et al. | State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. | 2013 | J Crohns Colitis | pmid:22917870 |
| Kochhar PK et al. | Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial. | 2013 | J. Obstet. Gynaecol. Res. | pmid:22925176 |
| Basora M et al. | Optimizing preoperative haemoglobin with intravenous iron. | 2013 | Br J Anaesth | pmid:23404979 |
| Yamamoto S et al. | Iatrogenic osteomalacia: report of two cases. | 2013 | J. UOEH | pmid:23475021 |
| GarcÃa Erce JA et al. | [Thoughts about the usefulness of the preoperatory administration of intravenous iron in hip fracture surgery]. | 2013 | Med Clin (Barc) | pmid:23790583 |
| Kowalczyk MC et al. | Effects of combined phytochemicals on skin tumorigenesis in SENCAR mice. | 2013 | Int. J. Oncol. | pmid:23835587 |
| Beguin Y et al. | Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial. | 2013 | Am. J. Hematol. | pmid:23873823 |
| Munoz C et al. | Klotho sensitivity of the hERG channel. | 2013 | FEBS Lett. | pmid:23603386 |
| Lynn S and McDaniel J | Managing severe anemia when the patient is a Jehovah's Witness. | 2013 | JAAPA | pmid:23610833 |
| Biggar P and Hahn KM | [Importance of the different i.v. iron generations for everyday medical practice]. | 2013 | MMW Fortschr Med | pmid:23678667 |
| Beck-da-Silva L et al. | IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. | 2013 | Int. J. Cardiol. | pmid:23680589 |
| Goldstein SL et al. | Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial. | 2013 | Am. J. Kidney Dis. | pmid:23245582 |
| Blanco Rubio N et al. | [Preoperative intravenous iron as a strategy for blood saving in surgery for hip fracture]. | 2013 | Med Clin (Barc) | pmid:23246172 |
| Lee ES et al. | Comparison of adverse event profile of intravenous iron sucrose and iron sucrose similar in postpartum and gynecologic operative patients. | 2013 | Curr Med Res Opin | pmid:23252876 |
| Bhattacharya S et al. | D-saccharic acid 1,4-lactone protects diabetic rat kidney by ameliorating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via NF-κB and PKC signaling. | 2013 | Toxicol. Appl. Pharmacol. | pmid:23261973 |
| Moore KL et al. | Uncommon adverse effect of a common medication. | 2013 | Tidsskr. Nor. Laegeforen. | pmid:23344600 |
| Froessler B et al. | Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial. | 2013 | J. Matern. Fetal. Neonatal. Med. | pmid:23130909 |
| Bhattacharya S et al. | The prophylactic role of D-saccharic acid-1,4-lactone against hyperglycemia-induced hepatic apoptosis via inhibition of both extrinsic and intrinsic pathways in diabetic rats. | 2013 | Food Funct | pmid:23138840 |
| Devasenapathy N et al. | Is intravenous iron sucrose the treatment of choice for pregnant anemic women? | 2013 | J. Obstet. Gynaecol. Res. | pmid:23167561 |
| Wilson PD et al. | An analysis of the health service efficiency and patient experience with two different intravenous iron preparations in a UK anaemia clinic. | 2013 | J Med Econ | pmid:22989163 |
| Douard V et al. | Excessive fructose intake causes 1,25-(OH)(2)D(3)-dependent inhibition of intestinal and renal calcium transport in growing rats. | 2013 | Am. J. Physiol. Endocrinol. Metab. | pmid:23571713 |
| Yang Z et al. | Parasitic nematode-induced modulation of body weight and associated metabolic dysfunction in mouse models of obesity. | 2013 | Infect. Immun. | pmid:23509143 |
| Potthoff SA and Münch HG | [Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease]. | 2013 | Dtsch. Med. Wochenschr. | pmid:23737117 |
| Janus N et al. | Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey. | 2013 | Support Care Cancer | pmid:23715817 |
| Giger M and Achermann R | [Iron substitution in outpatients in Switzerland: Increase of costs associated with intravenous administration]. | 2013 | Z Evid Fortbild Qual Gesundhwes | pmid:23916272 |
| Beck-da-Silva L et al. | Iron therapy in patients with heart failure. A straight shot. | 2013 | Int. J. Cardiol. | pmid:23931974 |
| Vadasz D et al. | Intravenous iron sucrose for restless legs syndrome in pregnant women with low serum ferritin. | 2013 | Sleep Med. | pmid:24012019 |
| Tian B et al. | Predicting enzyme-substrate specificity with QM/MM methods: a case study of the stereospecificity of (D)-glucarate dehydratase. | 2013 | Biochemistry | pmid:23901785 |
| Abdel-Razeq H et al. | Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study. | 2013 | Drug Des Devel Ther | pmid:24039403 |
| Kalaivani K | Use of intravenous iron sucrose for treatment of anaemia in pregnancy. | 2013 | Indian J. Med. Res. | pmid:24056552 |
| Kriplani A et al. | Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy. | 2013 | Indian J. Med. Res. | pmid:24056559 |
| Michigami T | [Updates on rickets and osteomalacia: FGF23-mediated hypophosphatemic rickets/osteomalacia]. | 2013 | Clin Calcium | pmid:24076640 |
| Italia K et al. | Hydroxyurea could be a good clinically relevant iron chelator. | 2013 | PLoS ONE | pmid:24349400 |
| Grim K et al. | Treatment of childhood-onset restless legs syndrome and periodic limb movement disorder using intravenous iron sucrose. | 2013 | Sleep Med. | pmid:23993871 |
| Athibovonsuk P et al. | Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy. | 2013 | Gynecol. Oncol. | pmid:24099839 |
| Ferumoxytol: an intravenous iron, riskier than iron sucrose. | 2013 | Prescrire Int | pmid:24171212 | |
| Rowlands M et al. | The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial. | 2013 | Trials | pmid:24015990 |
| Kumbasar A et al. | The effect of different doses and types of intravenous iron on oxidative stress and inflammation in hemodialysis patients. | 2012 Sep-Oct | J. Nephrol. | pmid:22307439 |
| Ozkurt S et al. | Acute and subacute effects of EV iron sucrose on endothelial functions in hemodialysis patients. | 2012 | Ren Fail | pmid:22017464 |
| Toblli JE et al. | Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat model. | 2012 | Inflamm Allergy Drug Targets | pmid:22309085 |
| Stachowska-Pietka J et al. | Computer simulations of osmotic ultrafiltration and small-solute transport in peritoneal dialysis: a spatially distributed approach. | 2012 | Am. J. Physiol. Renal Physiol. | pmid:22301624 |
| Muñoz M et al. | Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty. | 2012 | Br J Anaesth | pmid:22337966 |
| Freburger JK et al. | Changing patterns of anemia management in US hemodialysis patients. | 2012 | Am. J. Med. | pmid:22938926 |
| Christoph P et al. | Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. | 2012 | J Perinat Med | pmid:22945271 |
| Rostoker G et al. | Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study. | 2012 | Am. J. Med. | pmid:22998881 |
| Okam MM et al. | Comparative rates of adverse events with different formulations of intravenous iron. | 2012 | Am. J. Hematol. | pmid:22965928 |
| Borchard G et al. | Nanoparticle iron medicinal products - Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies. | 2012 | Regul. Toxicol. Pharmacol. | pmid:22951348 |
| Yamamoto S et al. | Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide. | 2012 | Intern. Med. | pmid:22975552 |
| Galutira PJ and Del Rio M | Understanding renal posttransplantation anemia in the pediatric population. | 2012 | Pediatr. Nephrol. | pmid:22086345 |
| Bespalov VG and Aleksandrov VA | [Anticarcinogenic effect of potassium salts of glucaric and glucuronic acid in induced models of cervical and esophageal tumors]. | 2012 | Vopr Onkol | pmid:23607211 |
| Lê BV et al. | Modulation of Pseudomonas aeruginosa lipopolysaccharide-induced lung inflammation by chronic iron overload in rat. | 2012 | FEMS Immunol. Med. Microbiol. | pmid:22066700 |
| Smith TN et al. | Modifications in the nitric acid oxidation of D-glucose. | 2012 | Carbohydr. Res. | pmid:22285512 |